Takeda Pharmaceutical (TAK) Non-Current Deferred Tax Liability (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Non-Current Deferred Tax Liability of $169.64 million for the quarter ended Jun 30, 2026, down 26.8% from $231.62 million a year earlier and down 0.7% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical's Non-Current Deferred Tax Liability came in at $178.06 million, down 22.8% from the prior year.
- Annual Non-Current Deferred Tax Liability has declined for seven consecutive years, with a five-year compound annual growth rate of -48.9% (years ended Mar 2021 to Mar 2026).
- In prior years, Takeda Pharmaceutical's Non-Current Deferred Tax Liability was $230.77 million in the year ended Mar 31, 2025 (-70.7%), $788.94 million in the year ended Mar 31, 2024 (-60.6%), $2 billion in the year ended Mar 31, 2023 (-50.2%) and $4.02 billion in the year ended Mar 31, 2022 (-21.5%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Non-Current Deferred Tax Liability since the quarter ended Sep 30, 2019.
- On a year-over-year basis, Non-Current Deferred Tax Liability has declined in each of the last 14 quarters, with an average decline of 44.6% over the last eight quarters.
- The year-over-year decline in Non-Current Deferred Tax Liability has ranged between 18.0% (the quarter ended Dec 31, 2025) and 81.9% (the quarter ended Jun 30, 2024) over the last five years.
- According to Business Quant data, Non-Current Deferred Tax Liability for the three prior quarters was $170.92 million (quarter ended Mar 31, 2026), $203.27 million (quarter ended Dec 31, 2025) and $224.16 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 169.64 Mn |
| Mar 31, 2026 | 170.92 Mn |
| Dec 31, 2025 | 203.27 Mn |
| Sep 30, 2025 | 224.16 Mn |
| Jun 30, 2025 | 231.62 Mn |
| Mar 31, 2025 | 230.41 Mn |
| Dec 31, 2024 | 247.78 Mn |
| Sep 30, 2024 | 312.54 Mn |
| Jun 30, 2024 | 356.59 Mn |
| Mar 31, 2024 | 767.75 Mn |
| Dec 31, 2023 | 900.02 Mn |
| Sep 30, 2023 | 1.58 Bn |
| Jun 30, 2023 | 1.97 Bn |
| Mar 31, 2023 | 2.05 Bn |
| Dec 31, 2022 | 2.75 Bn |
| Sep 30, 2022 | 3.37 Bn |
| Jun 30, 2022 | 3.53 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Jun 30, 2021 | 5.02 Bn |
| Mar 31, 2021 | 5.13 Bn |
API Access
Takeda Pharmaceutical Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();